1. Антелава О.А., Соловьев С.К,. Хитров А.Н, Насонов Е.Л. Новые аспекты фармакотерапии идиопатических воспалительных миопатий (Обзор литературы). Рус. мед. журн. 2006; 14 (8): 260, 627–9.
2. Бондаренко И.Б., Мухин Н.А., Насонов Е.Л. Поражение легких при полимиозите и дерматомиозите. Интерстициальные заболевания легких. Руководство для врачей. Под ред. М.М. Ильковича, А.Н. Кокосова. СПб.: Нордмедиздат, 2005: 274–87.
3. Бондаренко И.Б., Мухин Н.А., Насонов Е.Л. и др. Поражение легких при полимиозите и дерматомиозите. Клин. мед. 1998; 2: 20–4.
4. Насонов Е.Л., Штутман В.З., Саложин К.В. и др. Клинико-иммунологическая гетерогенность идиопатических воспалительных миопатий. Клин. мед. 1995; 2: 4–8.
5. Идиопатические воспалительные миопатии. Клинические рекомендации. Ревматология. М., 2005: 192–201.
6. Овчаренко С.И., Петухова Н.В., Слукина О.Г. Поражение легких по типу интерстициальной болезни у больной с дерматомиозитом. Новые Санкт-Петербургские врачебные ведомости. 2001; 2: 49–51.
7. Adansson JY. Radiation enhaces silica translocation to the pulmonary interstitium and increases fibrosis in mice. Environ Health Perspekt. 1992; 97: 233–8.
8. Asanuma Y, Yamada H, Matsuda T et al. Successful treatment of interstitial pneumonia with lipo-PGE1 and pentoxilylline in a patient with dermatomyositis. Ryumachi 1997; 37 (5): 719–26.
9. Bach GL, Stock K-P. Polymyositis/Dermatomyositis: Klinik, Aetiopathogenese und moegliche ausloesende Faktoren. Artritis + Rheuma 1992; 12 (1): 20–4.
10. Betteridge Z, Gunawardena H, North J et al. Anti-synthetase syndrome: a new autoantibody to phenylalanyl transfer RNA synthetase (anti-Zo) assotiated with polymyositis and interstitial pneumonia. Rheumatol 2007; 46: 1005–8.
11. Blechynden LM, Lawson MA, Tabarias H et al. Myositis induced by naked DNA immunization with the gene for hystidyl-tRNA. Hum Gene Ther 1997; 8 (12): 1469–80.
12. Duncan PE, Criffin JP, Garcia A. Fibrosing alveolitis in polymyositis: a review of histologically cases. Am J Med 1974; 57: 621–6.
13. Fathi М, Vikgren J, Boijsen M et al. Interstitial lung disease in Polymyositis and Dermatomyositis: longitudinal evaluation by pulmonary function and radiology. Arth Rheu (Arth Care Res) 2008; 59 (5): 677–85.
14. Hashish L, Trieu EP, Sadanandan P, Targoff IN. Identification of autoantibodies to tyrosyl-tRNA synthetase in dermatomyositis with features consistent with antisynthetase syndrome (absract). Arth Rheum 2005; 52 (Suppl. 9): 312.
15. Hirakata H, Suwa A, Takeda Y et al. Electronic cell conting to measure total cell numbers in bronchoalveolarlavage fluid. Eur Respir J 1994; 7: 1527–31.
16. Yoshifuji H, Fujii T, Kobayashi S et al. Anti-aminoacyl-tRNA synthetase antibodies in clinical course prediction of interstitial lung disease complicated with idiopathic inflammatory myopathies. Autoimmunity 2006; 39: 233–41.
17. Ishikawa S, Takei Y, Maruyama T, Koyama S, Hanyu N. A case of polymyositis presenting pregnancy with acute respiratory failure. Rinsho-Shinkeigaku 2000; 40 (2): 140–4.
18. Mаrir IE, Hachulla P, Erin S. Interstitial Lung Disease in Polymyositis and Dermatomyositis Arthritis & Rheumatism (Arth Res) 2002; 47 (6): 614–22.
19. Mills ES, Matheus WH. Interstitial pneumonitis in dermatomyositis. JAMA 1956; 160: 1467–70.
20. Nishikai M, Ohya K, Kosaka M et al. Anti-Jo-1 antibodies in polymyositis or dermatomyositis: evaluation by ELISA using recombinant fusion protein Jo-1 as antigen. Br J Rheumatol 1998; 37 (4): 357–61.
21. O'Leary PA, Waisman M. Dermatomyositis: A stady of forty cases. Arch.Dermatol.Syph 1940; 41: 1001–19.
22. Philips T, Leigh I, Wright J. Dermatomyositis and pulmonary fibrosis associated with anti-Jo-1 antibody. J of the Am Acad Dermatol 1988; 5: 381–2.
23. Rowen AJ, Reiched J. Dermatomyositiswith lung involvement treated with azathioprine. Resperation 1983; 44: 143–6.
24. Salaffi F, Carotti M, Baldelli S et al. Subclinical interstitial lung involvement in rheumatic diseases. Correlation of high resolution computerized tomography and functional and cytologic findings. Radiol Med Torino 1999; 97 (1–2): 33–41.